Immunological diseases of liver and gut : proceedings of Falk Symposium 135 held in Prague, Czech Republic, September 12-13, 2003 /
Saved in:
| Meeting name: | Falk Symposium (135th : 2003 : Prague, Czech Republic) |
|---|---|
| Imprint: | Dordrecht ; Boston : Kluwer Academic, c2004. |
| Description: | xiii, 306 p. : ill. ; 25 cm. |
| Language: | English |
| Series: | Falk symposium ; 135 Falk symposium (Series ; 135 |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/5529678 |
Table of Contents:
- List of Principal Contributors
- Preface
- Section I. Immunopathogenesis and Liver Diseases: Basic Principles
- 1. The liver as an immune organ
- 2. Immunogenetics of liver disease
- 3. Lipotoxicity and apoptosis in non-alcoholic fatty liver disease
- 4. Fibrogenesis, hepatic stellate cells and the immune system
- 5. Molecular characterization of autoantigens in autoimmune liver diseases
- 6. Immune mechanisms of viral clearance and pathogenesis of hepatitis C
- 7. Immune aspects of pathogenesis of alcoholic liver disease
- 8. Aetiology of primary biliary cirrhosis
- 9. Autoimmune hepatitis and overlap syndromes
- Section II. Immunopathogenesis and Liver Diseases: Clinical Implications
- 10. Primary sclerosing cholangitis
- 11. Immunological mechanisms of liver allograft rejection
- 12. Recurrence of autoimmune liver disease after liver transplantation
- 13. Human hepatic stem cells - potential for the future
- 14. Mucosal immunity, intestinal microflora and inflammatory bowel disease
- Section III. Immunopathological Mechanisms of Gut Inflammation
- 15. Genes and immunopathology
- 16. Defensins, innate immunity and the pathogenesis of inflammatory bowel disease
- 17. Progress of knowledge of immunopathogenesis in coeliac disease
- 18. Impact of immunodeficiency on immunological homeostasis in the gut
- Section IV. Immunopathology of the Gut: Clinical Aspects
- 19. Pathological versus clinical differential diagnosis in inflammatory bowel disease
- 20. Refractory sprue - what it is and what to do
- 21. Collagenous and lymphocytic colitis: distinct disorders or part of the spectrum of inflammatory bowel disease?
- 22. Predictive factors of the course and therapeutic response in inflammatory bowel disease
- Section V. Therapeutic Consequences of Immunopathological Processes in Inflammatory Bowel Disease
- 23. Efficacy and limits of immunomodulators in inflammatory bowel disease: azathioprine, 6-mercaptopurine, methotrexate and mycophenolate mofetil
- 24. Does 6-thioguanine therapy represent a new promising therapeutic modality?
- 25. Anti-tumour necrosis factor therapy in clinical practice: what is advance and what is not?
- 26. New possibilities in anticytokine therapy for inflammatory bowel disease
- 27. Medical therapy of inflammatory bowel disease: current state and perspectives in the future
- Index
